276 related articles for article (PubMed ID: 38048064)
1. The 5th Kidney Cancer Research Summit: Research Accelerating Cures for Renal Cell Carcinoma in 2023.
Choueiri TK; Pal SK; Lewis B; Poteat S; Pels K; Hammers H
Oncologist; 2024 Feb; 29(2):91-98. PubMed ID: 38048064
[TBL] [Abstract][Full Text] [Related]
2. Summary From the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research.
Choueiri TK; Atkins MB; Bakouny Z; Carlo MI; Drake CG; Jonasch E; Kapur P; Lewis B; Linehan WM; Mitchell MJ; Pal SK; Pels K; Poteat S; Rathmell WK; Rini BI; Signoretti S; Tannir N; Uzzo R; Wood CG; Hammers HJ
J Natl Cancer Inst; 2021 Mar; 113(3):234-243. PubMed ID: 32359162
[TBL] [Abstract][Full Text] [Related]
3. From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit.
Choueiri TK; Albiges L; Atkins MB; Bakouny Z; Bratslavsky G; Braun DA; Haas NB; Haanen JBAG; Hakimi AA; Jewett MAS; Jonasch E; Kaelin WG; Kapur P; Labaki C; Lewis B; McDermott DF; Pal SK; Pels K; Poteat S; Powles T; Rathmell WK; Rini BI; Signoretti S; Tannir NM; Uzzo RG; Hammers HJ
Clin Cancer Res; 2022 Mar; 28(5):831-839. PubMed ID: 34965942
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in Renal Cell Carcinoma: The Future Is Now.
Deleuze A; Saout J; Dugay F; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Crouzet L; Laguerre B; Belaud-Rotureau MA; Rioux-Leclercq N; Kammerer-Jacquet SF
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260578
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?
Anselmo Da Costa I; Rausch S; Kruck S; Todenhöfer T; Stenzl A; Bedke J
Expert Rev Anticancer Ther; 2017 Apr; 17(4):357-368. PubMed ID: 28162024
[TBL] [Abstract][Full Text] [Related]
6. Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma.
Jian Y; Yang K; Sun X; Zhao J; Huang K; Aldanakh A; Xu Z; Wu H; Xu Q; Zhang L; Xu C; Yang D; Wang S
Front Immunol; 2021; 12():639636. PubMed ID: 33767709
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in immunotherapy for kidney cancer.
Ball MW; Allaf ME; Drake CG
Discov Med; 2016 Apr; 21(116):305-13. PubMed ID: 27232516
[TBL] [Abstract][Full Text] [Related]
8. From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma.
Anker J; Miller J; Taylor N; Kyprianou N; Tsao CK
Cells; 2021 Nov; 10(11):. PubMed ID: 34831452
[TBL] [Abstract][Full Text] [Related]
9. Immune therapy for kidney cancer: a second dawn?
McDermott DF; Atkins MB
Semin Oncol; 2013 Aug; 40(4):492-8. PubMed ID: 23972713
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy in renal cell carcinoma: A booming clinical research].
Baize N; Bigot P
Prog Urol; 2018 Mar; 28(3):137-145. PubMed ID: 29339141
[TBL] [Abstract][Full Text] [Related]
11. Prognostic markers and targeted therapies for renal cell carcinoma.
Gimenez SE; Secasan C; Raman JD
Future Oncol; 2009 Mar; 5(2):197-205. PubMed ID: 19284378
[TBL] [Abstract][Full Text] [Related]
12. New immunotherapy in the treatment of advanced renal cancer.
Muto A; Gridelli C
Expert Opin Emerg Drugs; 2019 Dec; 24(4):233-237. PubMed ID: 31751164
[No Abstract] [Full Text] [Related]
13. State of the Future: Translational Approaches in Renal Cell Carcinoma in the Immunotherapy Era.
Bakouny Z; Flippot R; Braun DA; Lalani AA; Choueiri TK
Eur Urol Focus; 2020 Jan; 6(1):37-40. PubMed ID: 30827939
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy for Renal Cell Carcinoma].
Büchler T
Klin Onkol; 2015; 28 Suppl 4():4S64-8. PubMed ID: 26647891
[TBL] [Abstract][Full Text] [Related]
15. Current management and future perspectives of metastatic renal cell carcinoma.
Lee-Ying R; Lester R; Heng D
Int J Urol; 2014 Sep; 21(9):847-55. PubMed ID: 24862210
[TBL] [Abstract][Full Text] [Related]
16. Predicting response to interleukin-2 therapy among patients with renal cell carcinoma.
Leppert JT; Lam JS; Belldegrun AS
J Immunother; 2005; 28(5):427-9. PubMed ID: 16113598
[No Abstract] [Full Text] [Related]
17. Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.
Surolia I; Gulley J; Madan RA
Expert Opin Biol Ther; 2014 Dec; 14(12):1769-81. PubMed ID: 25212872
[TBL] [Abstract][Full Text] [Related]
18. Emerging role for novel immunotherapy agents in metastatic renal cell carcinoma: from bench to bedside.
Weinstock M; McDermott DF
Am Soc Clin Oncol Educ Book; 2015; ():e291-7. PubMed ID: 25993188
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-based immunotherapy of renal cell carcinoma.
Gitlitz BJ; Figlin RA; Pantuck AJ; Belldegrun AS
Curr Urol Rep; 2001 Feb; 2(1):46-52. PubMed ID: 12084295
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for renal cell carcinoma.
Sheng IY; Rini BI
Expert Opin Biol Ther; 2019 Sep; 19(9):897-905. PubMed ID: 31173514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
